Skip to content

A clinical trial to study the effect of Ayurvedic and Allopathic Treatment in the patients of Knee Osteoarthritis

A comparative clinical study of effectiveness of Ayurvedic and Conventional management in the patients of Sandhigata Vata of Janu (Knee osteoarthritis) with special reference to quality of life

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026737
Enrollment
120
Registered
2020-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee Health Condition 2: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Trayodashang guggulu 500mg Sahacharadi taila: Trayodashang guggulu tablet two tablets twice a day with lukewarm water along with local application of sahacharadi taila twice a day for f

Sponsors

central council for research in ayurvedica sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the Revised ACR 2016 criteria of Knee OA 2.Patients presenting with classical signs & symptoms of Osteoarthritis Knee 3.Patientsâ?? age group between 50 years to 70 years irrespective of sex, religion, occupation and socioeconomic status. 4.Pain severity scale on VAS between 1 to 6 (i.e. mild to moderate) 5.Patients with BMD range of > -1.0 to -3.0 6.Patient with BMI >18.5 to 7.Patients who are willing to this trial.

Exclusion criteria

Exclusion criteria: 1.Patients not fulfilling the Revised ACR 2016 criteria of Knee OA 2.Patients not fulfilling the classical sign and symptoms of OA. 3.Patientâ??s age group 70 years. 4.Patients with BMD range of 5.Patient with BMI 29.9 (WHO) 6.Pain severity scale on VAS 6. 7.Patients having systemic disorder (Diabetic mellitus, Hypertension and other illness ) which might interfere with the treatment. 8.Patient of Autoimmune disorders, metabolic joint disorders or other than OA. 9.Patients with infective Neoplastic and traumatic condition of Knee joint.

Design outcomes

Primary

MeasureTime frame
Any change in western Ontario and McMaster University osteoarthritis (WOMAC) score from baseline to the end of 3rd, 6th and 9th weeks of follow upsTimepoint: 63days

Secondary

MeasureTime frame
ï?§Assessment of changes in (clinical symptoms) subjective parameters and objective parameters from baseline to the end of 3rd, 6th and 9th weeks. ï?§Assessment of quality of life by using World Health Organization Quality of life (WHOQOL) BREF questionnaire.Timepoint: 63days

Countries

India

Contacts

Public ContactDr Ajai kumar pandey

Intitute of Medical Science Banaras Hindu University

drrashmikathait@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026